It's not known if the new Bombali virus can spread to people, but it has the potential to enter human cells.
In an update yesterday that came a day after the Democratic Republic of Congo's (DRC's) Ebola outbreak was declared over, the World Health Organization (WHO) said it now considers the risk to the region and the rest of the world as low.
Prenatal dengue infection may increase the risk of any neurologic congenital anomaly in an infant by roughly 50%, according to new research published yesterday in Emerging Infectious Diseases.
The declaration comes just 11 weeks after health officials sounded the alarm about the outbreak in early May.
The Liberian case from 2015 highlights a lingering threat that the DRC will face after its outbreak is declared over.
Public Health England (PHE) yesterday released its provisional seasonal flu vaccine effectiveness (VE) estimates for the 2017-18 flu season, which revealed low overall effectiveness and no protection against H3N2, but variable findings in different age-groups.
A report summing up all the investigation findings in India's Nipah virus outbreak says 17 of 19 patients appear to have contracted the virus from the index patient, a 26-year-old man, Press Trust of India (PTI) reported yesterday, citing findings released by health officials from Kerala state.
The US Food and Drug Administration (FDA) today approved TPOXX (tecovirimat), made by SIGA Technologies, as the first drug with an indication for treating smallpox, a disease that has been eradicated but could still be used as a bioweapon.
Depression, headaches, and insomnia are just some of the often debilitating symptoms.
A study published in Vaccine shows that even small doses of the yellow fever vaccine are likely to offer protection against the virus for up to 8 years after vaccination. The information reassures countries like Brazil, who have used fractional dosing in an effort to stretch supplies of the vaccine during recent outbreaks.
